Francisco Vega

Professor of Clinical

  • 3510 Citations
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research interests

  • socio-cultural issues in music education

Fingerprint Dive into the research topics where Francisco Vega is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
B-Lymphocytes Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
T-Cell Lymphoma Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

Erratum: CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis (Cancer Cell (2018) 33(6) (1111–1127.e5), (S1535610818302216), (10.1016/j.ccell.2018.05.007))

Greenblatt, S. M., Man, N., Hamard, P. J., Asai, T., Karl, D., Martinez, C., Bilbao, D., Stathias, V., Jermakowicz, A. M., Duffort, S., Tadi, M., Blumenthal, E., Newman, S., Vu, L., Xu, Y., Liu, F., Schuerer, S. C., McCabe, M. T., Kruger, R. G., Xu, M. & 5 others, Yang, F-C., Tenen, D. G., Watts, J., Vega, F. & Nimer, S. D., Jan 14 2019, In : Cancer Cell. 35, 1, 1 p.

Research output: Contribution to journalComment/debate

coactivator-associated arginine methyltransferase 1

Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma

Khashab, T., Hagemeister, F., Romaguera, J. E., Fanale, M. A., Pro, B., McLaughlin, P., Rodriguez, M. A., Neelapu, S. S., Fayad, L., Younes, A., Feng, L., Vega, F., Kwak, L. W. & Samaniego, F., May 1 2019, In : British Journal of Haematology. 185, 4, p. 670-678 9 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Disease-Free Survival
Survival Rate
1 Citation (Scopus)

Mechanisms of lymphoma clearance induced by high-dose alkylating agents

Lossos, C., Liu, Y., Kolb, K. E., Christie, A. L., Van Scoyk, A., Prakadan, S. M., Shigemori, K., Stevenson, K. E., Morrow, S., Plana, O. D., Fraser, C., Jones, K. L., Liu, H., Pallasch, C. P., Modiste, R., Nguyen, Q. D., Craig, J. W., Morgan, E. A., Vega, F., Aster, J. C. & 4 others, Sarosiek, K. A., Shalek, A. K., Hemann, M. T. & Weinstock, D. M., Jul 1 2019, In : Cancer Discovery. 9, 7, p. 944-961 18 p.

Research output: Contribution to journalArticle

Alkylating Agents
Bone Marrow

Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation

Alderuccio, J. P., Zhao, W., Desai, A., Ramdial, J., Gallastegui, N., Kimble, E., De La Fuente, M. I., Husnain, M., Rosenblatt, J. D., Alencar, A. J., Schatz, J. H., Moskowitz, C., Chapman-Fredricks, J., Vega, F., Reis, I. & Lossos, I., Jan 1 2019, In : American Journal of Hematology.

Research output: Contribution to journalArticle

Disease-Free Survival
Marginal Zone B-Cell Lymphoma